Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of SL77.0499-10 10mg Once Daily in Comparison With Placebo and Tamsulosin Hydrochloride 0.2mg in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia (BPH).

NCT00399464 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00399464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00399464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of SL77.0499-10 10mg Once Daily in Comparison With Placebo and Tamsulosin Hydrochloride 0.2mg in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia (BPH).
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2006
Completion date
October 31, 2007
Enrollment
1,177 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic hyperplasia